Considerations for use of probiotic bacteria to modulate human health.
about
Probiotics and medical nutrition therapyMultiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.Genetic and proteomic analysis of factors affecting serum cholesterol reduction by Lactobacillus acidophilus A4.Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.Multiple-unit tablet of probiotic bacteria for improved storage stability, acid tolerability, and in vivo intestinal protective effect.Persistence of colicinogenic Escherichia coli in the mouse gastrointestinal tract.Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gutAn in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering propertiesBacillus polyfermenticus ameliorates colonic inflammation by promoting cytoprotective effects in colitic mice.Preliminary characterization of the probiotic properties of Candida famata and Geobacillus thermoleovorans.Complete Genome Sequence of Lactobacillus casei LC5, a Potential Probiotics for Atopic DermatitisComparison of Microbial Diversity of Korean Commercial Makgeolli Showing High β-Glucan Content and High Antihypertensive Activity, Respectively.Optimization of cholesterol removal by probiotics in the presence of prebiotics by using a response surface method.Evaluation of kefir as a potential probiotic on growth performance, serum biochemistry and immune responses in broiler chicks.In vitro assessment of MTC 1032 as the potential probiotic in food supplements
P2860
Q24548441-0AADDFF3-5F50-49BC-9D23-8D38A0C5A167Q33684740-7DD0AE5E-ABD1-4AF0-B322-F67300A27C58Q33983528-9CE23DEB-05B0-495D-9126-2DF28D65F3CEQ34579758-6738F797-2444-4F2C-8D66-0AE8D3D7D281Q36787759-54E81B90-7EC9-4C8B-96B8-7DB000AD664EQ37341276-9E3AA689-8FC7-4B0F-A8AF-32DD2FD6B0C9Q39640631-DFD7B786-4294-4DF3-9679-6DE5FD26DEE6Q39804998-42A1283F-1F80-4E37-8F47-9ECA87FD103DQ39813347-B78B41F9-3A28-49C0-B3E4-51A9DDA5F131Q41130903-03280092-2A51-4623-99FA-F9015E602E5BQ41864813-BDC2FD43-3DF1-4580-9A96-CE679DB48BBCQ42255361-ADABB9E3-9F32-4520-B10E-E0BDC2868FE1Q42722882-0DDACAF2-F8F1-4291-BD91-1F648DA7A2B5Q54209831-A74030A7-FA30-403D-BE41-94600E50565CQ57115856-DAEA4FE0-5F89-49AF-A5E2-06B93C2A24F9
P2860
Considerations for use of probiotic bacteria to modulate human health.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Considerations for use of probiotic bacteria to modulate human health.
@ast
Considerations for use of probiotic bacteria to modulate human health.
@en
type
label
Considerations for use of probiotic bacteria to modulate human health.
@ast
Considerations for use of probiotic bacteria to modulate human health.
@en
prefLabel
Considerations for use of probiotic bacteria to modulate human health.
@ast
Considerations for use of probiotic bacteria to modulate human health.
@en
P356
P1433
P1476
Considerations for use of probiotic bacteria to modulate human health.
@en
P2093
Sanders ME
P304
P356
10.1093/JN/130.2.384S
P407
P433
P577
2000-02-01T00:00:00Z